465 related articles for article (PubMed ID: 26433882)
1. Role of Smad signaling in kidney disease.
Zhang Y; Wang S; Liu S; Li C; Wang J
Int Urol Nephrol; 2015 Dec; 47(12):1965-75. PubMed ID: 26433882
[TBL] [Abstract][Full Text] [Related]
2. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
3. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
Lan HY
Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
5. TGF-β/Smad signaling in kidney disease.
Lan HY; Chung AC
Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
[TBL] [Abstract][Full Text] [Related]
6. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
7. Nanosized titanium dioxide resulted in the activation of TGF-β/Smads/p38MAPK pathway in renal inflammation and fibration of mice.
Hong F; Wu N; Ge Y; Zhou Y; Shen T; Qiang Q; Zhang Q; Chen M; Wang Y; Wang L; Hong J
J Biomed Mater Res A; 2016 Jun; 104(6):1452-61. PubMed ID: 26850371
[TBL] [Abstract][Full Text] [Related]
8. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Meng XM; Chung AC; Lan HY
Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
[TBL] [Abstract][Full Text] [Related]
9. Regulation of TGF-β Family Signaling by Inhibitory Smads.
Miyazawa K; Miyazono K
Cold Spring Harb Perspect Biol; 2017 Mar; 9(3):. PubMed ID: 27920040
[TBL] [Abstract][Full Text] [Related]
10. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W
J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs.
Tang PM; Zhang YY; Mak TS; Tang PC; Huang XR; Lan HY
J Physiol; 2018 Aug; 596(16):3493-3503. PubMed ID: 29781524
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
[TBL] [Abstract][Full Text] [Related]
13. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F; Liu C; Zhou D; Zhang L
J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.
Carvajal G; Rodríguez-Vita J; Rodrigues-Díez R; Sánchez-López E; Rupérez M; Cartier C; Esteban V; Ortiz A; Egido J; Mezzano SA; Ruiz-Ortega M
Kidney Int; 2008 Sep; 74(5):585-95. PubMed ID: 18509316
[TBL] [Abstract][Full Text] [Related]
15. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
16. Nur77 ameliorates age-related renal tubulointerstitial fibrosis by suppressing the TGF-β/Smads signaling pathway.
Ma G; Chen F; Liu Y; Zheng L; Jiang X; Tian H; Wang X; Song X; Yu Y; Wang D
FASEB J; 2022 Feb; 36(2):e22124. PubMed ID: 34972249
[TBL] [Abstract][Full Text] [Related]
17. Smads as intracellular mediators of airway inflammation.
Groneberg DA; Witt H; Adcock IM; Hansen G; Springer J
Exp Lung Res; 2004; 30(3):223-50. PubMed ID: 15195555
[TBL] [Abstract][Full Text] [Related]
18. Smad7 as a therapeutic agent for chronic kidney diseases.
Lan HY
Front Biosci; 2008 May; 13():4984-92. PubMed ID: 18508563
[TBL] [Abstract][Full Text] [Related]
19. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
20. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.
Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE
J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]